174 related articles for article (PubMed ID: 6345238)
1. Effects of species of origin, purification levels, and formulation on insulin immunogenicity.
Fineberg SE; Galloway JA; Fineberg NS; Goldman J
Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238
[TBL] [Abstract][Full Text] [Related]
2. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
[TBL] [Abstract][Full Text] [Related]
3. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
[TBL] [Abstract][Full Text] [Related]
4. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).
Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ
Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant DNA human insulin.
Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ; Hufferd S
Diabetologia; 1983 Dec; 25(6):465-9. PubMed ID: 6198228
[TBL] [Abstract][Full Text] [Related]
6. [Purity and antigenicity of the new insulin preparations].
Fankhauser S
Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of new insulins.
Deckert T
Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
[TBL] [Abstract][Full Text] [Related]
8. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
Fireman P; Fineberg SE; Galloway JA
Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
[TBL] [Abstract][Full Text] [Related]
9. Circulating antibodies in diabetics treated with conventional and purified insulins.
Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
[TBL] [Abstract][Full Text] [Related]
10. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
11. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
12. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
13. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
Kühnau J; Rüdiger H; Goetz K
Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
[TBL] [Abstract][Full Text] [Related]
14. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of insulin of various origins.
Reeves WG
Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
[No Abstract] [Full Text] [Related]
16. Subpopulations of antibodies directed against evolutionarily conserved regions of the insulin molecule in insulin-treated patients.
Karlsson F; Harrison LC; Kahn CR; Itin A; Roth J
Diabetologia; 1982 Dec; 23(6):488-93. PubMed ID: 6759274
[TBL] [Abstract][Full Text] [Related]
17. Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purity.
Iavicoli M; Ventriglia L; Di Mario U; Galfo C; Andreani D
Diabetologia; 1983 Jan; 24(1):26-9. PubMed ID: 6186559
[TBL] [Abstract][Full Text] [Related]
18. Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.
Nell LJ; Virta VJ; Thomas JW
J Clin Invest; 1985 Dec; 76(6):2070-7. PubMed ID: 2416775
[TBL] [Abstract][Full Text] [Related]
19. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
[TBL] [Abstract][Full Text] [Related]
20. Insulin allergy: reaginic antibodies to insulin and proinsulin.
Kumar D; Rosenquist RJ; Parameswaran V
J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
